American Diabetes Association
Browse
cd22-0068_Supplementary_Material.docx (21.39 kB)

Facilitators and Barriers to Smart Insulin Pen Use: A Mixed-Method Study of Multidisciplinary Stakeholders From Diabetes Teams in the United States

Download (21.39 kB)
figure
posted on 2022-09-15, 16:21 authored by Emma Ospelt, Nudrat Noor, Janine Sanchez, Grace Nelson, Nicole Rioles, Faisal S. Malik, Marina Basina, Justin Indyk, Francesco Vendrame, Jessica Schmitt, Mary L. Scott, Osagie Ebekozien, T1D Exchange Quality Improvement Collaborative

  

This study sought to identify barriers and facilitators to successful smart insulin pen (SIP) use and gauge prescribing practices and integration into clinical practice by assessing provider and care team perspectives at participating endocrinology clinics within the T1D Exchange Quality Improvement Collaborative. The identified provider-related, patient-related, and clinic- and operational-level barriers and facilitators varied based on clinic knowledge, capacity, and resources. High-impact barriers included insurance coverage and prescribing processes; high-impact facilitators included improved diabetes clinic visit quality and use of SIPs as an alternative to insulin pump therapy. Findings indicated the need for provider and care team education and training on proper SIP features, use, and prescribing.

Funding

Medtronic Foundation

History

Usage metrics

    Clinical Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC